These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 1161676)
1. Treatment of an adrenal cortical carcinoma with a combination of o,p'-DDD and aminoglutethimide. Scott RD Postgrad Med J; 1975 Jan; 51(591):35-7. PubMed ID: 1161676 [TBL] [Abstract][Full Text] [Related]
2. [The effects of o,p'-DDD on human adrenal steroid synthesis]. Ojima M; Saito M; Fukuchi S Nihon Naibunpi Gakkai Zasshi; 1984 Jul; 60(7):852-71. PubMed ID: 6094274 [TBL] [Abstract][Full Text] [Related]
3. Current therapeutic concepts--Cushing's syndrome. Kishi DT J Am Pharm Assoc; 1975 May; 15(5):261-70. PubMed ID: 164494 [No Abstract] [Full Text] [Related]
4. Significant regression of the tumor combined with the high level of plasma cortisol by low-dose administration of O, p'-DDD in a case with Cushing's syndrome caused by adrenocortical carcinoma. Otokida K; Nakamura M; Takeda M; Ito T; Kato M; Masuda T; Tashiro A Tohoku J Exp Med; 1986 Dec; 150(4):407-15. PubMed ID: 3564003 [TBL] [Abstract][Full Text] [Related]
10. [Agents inhibiting steroid biosynthesis--aminoglutethimide and o,p'-DDD]. Aida M; Miura K Nihon Rinsho; 1974 Nov; 32(11):3257-61. PubMed ID: 4375206 [No Abstract] [Full Text] [Related]
11. Complete response of metastasized adrenal cortical carcinoma with o,p'-DDD. Case report and literature review. Boven E; Vermorken JB; van Slooten H; Pinedo HM Cancer; 1984 Jan; 53(1):26-9. PubMed ID: 6360329 [TBL] [Abstract][Full Text] [Related]
12. Treatment of adrenal cortical carcinoma with mitotane: outcome and complications. Lim MC; Tan YO; Chong PY; Cheah JS Ann Acad Med Singap; 1990 Jul; 19(4):540-4. PubMed ID: 2171414 [TBL] [Abstract][Full Text] [Related]
13. [Synthetic cortisol antagonists in the treatment of adrenal gland hypercortisolism. Results of 8 years of use]. Bricaire H; Luton JP Therapie; 1974; 29(5):645-58. PubMed ID: 4462221 [No Abstract] [Full Text] [Related]
14. The effect of o,p'-DDD on adrenal steroid replacement therapy requirements. Robinson BG; Hales IB; Henniker AJ; Ho K; Luttrell BM; Smee IR; Stiel JN Clin Endocrinol (Oxf); 1987 Oct; 27(4):437-44. PubMed ID: 2830062 [TBL] [Abstract][Full Text] [Related]
15. Adrenocortical carcinoma. A clinical study and treatment results of 52 patients. Kasperlik-Załuska AA; Migdalska BM; Zgliczyński S; Makowska AM Cancer; 1995 May; 75(10):2587-91. PubMed ID: 7736405 [TBL] [Abstract][Full Text] [Related]
16. Regression of an adrenal cortical carcinoma and its neovascular bed following mitotane therapy: a case report. Downing V; Eule J; Huseby RA Cancer; 1974 Dec; 34(6):1882-7. PubMed ID: 4434322 [No Abstract] [Full Text] [Related]
17. Malignant melanoma with ectopic production of adrenocorticotropic hormone. Palliative treatment with inhibitors of adrenal steroid biosynthesis. Carey RM; Orth DN; Hartmann WH J Clin Endocrinol Metab; 1973 Mar; 36(3):482-7. PubMed ID: 4119547 [No Abstract] [Full Text] [Related]
18. Complete remission of metastasized adrenocortical carcinoma under o,p'-DDD. Kornely E; Schlaghecke R Exp Clin Endocrinol; 1994; 102(1):50-3. PubMed ID: 8005209 [TBL] [Abstract][Full Text] [Related]
19. [Carcinoma of the adrenal cortex]. Hamborg B; Frey H; Bøhmer T; Norman N Tidsskr Nor Laegeforen; 1990 Mar; 110(8):956-9. PubMed ID: 2321225 [TBL] [Abstract][Full Text] [Related]
20. [Associated role of surgery and antimitotic o, p'-DDD treatment in hyperfunctioning adrenal cancers with diffuse metastases]. Perigli G; Borrelli D; Salvatore S; Cicchi P; Burci P Chir Ital; 1981 Feb; 33(1):122-34. PubMed ID: 6167374 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]